Allergic Contact Dermatitis from Dyes in Wigs Following Diphenylcyclopropenone Treatment

    September 2004 in “ Contact dermatitis ”
    Sharon M. Crichlow, A P Warin
    Image of study
    TLDR Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.
    A 36-year-old woman with alopecia universalis developed severe allergic contact dermatitis from dyes in wigs following diphencyprone (DPCP) treatment. She experienced severe scalp and generalized eczema without hair regrowth, leading to discontinuation of DPCP. Patch testing revealed a strong reaction to para-phenylenediamine (PPD) in the wig dyes. Despite attempts to use barrier methods and switch to human-hair wigs without dyes, she continued to experience scalp dermatitis. Significant improvement was achieved by avoiding dyed wigs and clothing. This case highlighted the potential for severe allergic reactions to dyes following DPCP treatment, emphasizing the need for careful management of contact allergens in patients undergoing such treatments.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community No hair, don't care! [24/F] :)

       61 upvotes 8 years ago
      A woman with alopecia universalis shares her positive experience of being bald, finding it freeing and less worrisome. She also discusses her skincare routine using Korean products.

      community Olumiant alternative for Alopecia Areata?

      in Treatment  1 upvotes 1 year ago
      A user with alopecia areata is considering treatment options like injections or Olumiant but is concerned about cost and whether delaying treatment will lead to permanent hair loss. They are seeking alternative treatments that are more affordable for a college student.

      community Scalp, eyebrow, eyelash and pubic hair loss.

       6 upvotes 6 years ago
      The user experienced significant hair loss on the scalp, eyebrows, eyelashes, and pubic area, along with itchy, flaky skin and red patches. They have a history of eczema and dermatitis and suspect that stopping shampoo use and taking Ritalin may have contributed to the issue.

      community Just find a cure already, I am totally done

      in Chat  161 upvotes 5 months ago
      The conversation is about hair loss treatments, with users recommending finasteride and minoxidil as effective solutions. Some users report side effects, but overall, the consensus is to use these treatments rather than waiting for a cure.

    Similar Research

    5 / 1000+ results
      British Hair and Nail Society

      research British Hair and Nail Society

      July 2018 in “British Journal of Dermatology”
      Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.
      Update on the Treatment of Alopecia Areata

      research Update on the Treatment of Alopecia Areata

      11 citations, May 2009 in “Actas Dermo-Sifiliográficas”
      Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.
      Drug Armamentarium for Alopecia Areata

      research Drug Armamentarium for Alopecia Areata

      February 2021 in “Journal of pharmaceutical and biological sciences”
      No cure exists for alopecia areata, and treatments are personalized.
      Compounding as a Current Therapeutic Option in Dermatology

      research Compounding as a Current Therapeutic Option in Dermatology

      1 citations, October 2013 in “Actas Dermo-Sifiliográficas”
      Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.